Clinical Trial Update: A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating first-line treatment of metastatic pancreatic cancer using a combination of TQB2916 with gemcitabine and nab-paclitaxe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine hydrochloride for Injection (Gemcitabine)
• Paclitaxel for Injection (Albumin-bound) (Paclitaxel (Albumin-bound))
• TQB2916

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING